The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Oncocross
Honoraria - Bayer; Ipsen; SERVIER
Consulting or Advisory Role - LSK BioPharma
Speakers' Bureau - Bayer; Celgene; Eisai; Ipsen; Merck Sharp & Dohme
Research Funding - AstraZeneca; Bayer; CKD pharm; SERVIER
 
Speakers' Bureau - Bayer Health
Travel, Accommodations, Expenses - PharmaMar
A phase Ib/II study of olutasidenib in patients with relapsed/refractory IDH1 mutant solid tumors: Safety and efficacy as single agent.
 
Robin Lewis Jones
Consulting or Advisory Role - Adaptimmune; Blueprint Medicines; Clinigen Group; Daiichi Sankyo; Deciphera; Eisai; Epizyme; Immodulon Therapeutics; Immune Design; Lilly; Merck Serono; Morphotek; PharmaMar; TRACON Pharma
Research Funding - GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Teresa Macarulla
Consulting or Advisory Role - Baxalta; Baxter; Celgene; Incyte; Ipsen; Lilly; QED Therapeutics; Roche; Sanofi/Aventis; SERVIER; Shire
Research Funding - Agios (Inst); ASLAN Pharmaceuticals (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Genentech (Inst); Halozyme (Inst); Immunomedics (Inst); Lilly (Inst); Merrimack (Inst); Millennium (Inst); Novartis (Inst); Novocure (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Celgene; H3 Biomedicine; Merck; Sanofi; SERVIER
 
John A. Charlson
Research Funding - Lilly (Inst)
Travel, Accommodations, Expenses - Lilly
 
Brian Andrew Van Tine
Leadership - Polaris
Consulting or Advisory Role - Adaptimmune; Bayer; Caris Life Sciences; CytRx Corporation; Daiichi Sankyo; EMD Serono; Epizyme; GlaxoSmithKline; Immune Design; Johnson & Johnson; Lilly/ImClone; Novartis; Pfizer; Plexxikon; Threshold Pharmaceuticals
Speakers' Bureau - Adaptimmune; Caris Life Sciences; GlaxoSmithKline; Johnson & Johnson; Lilly; Novartis
Research Funding - GlaxoSmithKline; Merck; Pfizer; TRACON Pharma
Patents, Royalties, Other Intellectual Property - Patent on ALEXT3102; Patent on the use of ME1 as a biomarker
Travel, Accommodations, Expenses - Adaptimmune; Advenchen Laboratories; Lilly
 
Lipika Goyal
Consulting or Advisory Role - Agios; Alentis Therapeutics; AstraZeneca; Debiopharm Group; H3 Biomedicine; Klus Pharma; QED Therapeutics; Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
Travel, Accommodations, Expenses - Debiopharm Group; Taiho Pharmaceutical
 
Antoine Italiano
Honoraria - Bayer; Daiichi Sankyo; Epizyme; IPSEN; Lilly; Novartis; Roche
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Epizyme; Immune Design; Lilly; Roche
Research Funding - AstraZeneca/MedImmune; Bayer; Merck Serono; Merck Serono; MSD Oncology; PharmaMar; Roche
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
 
Christophe Massard
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Debiopharm Group; Genentech/Roche; INNATE PHARMA; IPSEN; Janssen; Lilly; MSD; Novartis; Orion; Pfizer; PharmaMar; Sanofi; Taiho Pharmaceutical
 
Mark Rosenthal
No Relationships to Disclose
 
Macarena Ines De La Fuente
Consulting or Advisory Role - Agios; FORMA Therapeutics; Foundation Medicine; Puma Biotechnology
Other Relationship - OncLIve (I); Oncology Information Group (I); Targeted Oncology (I)
 
Patricia Roxburgh
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst); Athenex (Inst); Clovis Oncology (Inst); FORMA Therapeutics (Inst); Immutep (Inst); Iovance Biotherapeutics (Inst); Nucana (Inst); PsiOxus Therapeutics (Inst); Replimune (Inst); Sierra Oncology (Inst); Starpharma (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Madappa N. Kundranda
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb
Speakers' Bureau - Amgen; Bayer Health
Research Funding - Celgene
 
Jean-Yves Blay
Leadership - Innate Pharma
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; PharmaMar; Roche
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Pharmamar; Roche
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Changhoon Yoo
No Relationships to Disclose
 
Kate Lipford
Employment - FORMA Therapeutics
Stock and Other Ownership Interests - FORMA Therapeutics
 
Sanjeev Forsyth
Employment - FORMA Therapeutics
Stock and Other Ownership Interests - FORMA Therapeutics
 
Sylvie Mireille Guichard
Employment - FORMA Therapeutics
Stock and Other Ownership Interests - FORMA Therapeutics
 
Yelena Mikhailov
Employment - FORMA Therapeutics
Stock and Other Ownership Interests - FORMA Therapeutics
 
Blythe Thomson
Employment - FORMA Therapeutics
Travel, Accommodations, Expenses - FORMA Therapeutics; FORMA Therapeutics
 
Patrick Francis Kelly
Employment - FORMA Therapeutics
Stock and Other Ownership Interests - FORMA Therapeutics
 
Florence Duffaud
No Relationships to Disclose